Literature DB >> 10193997

Role of cyclooxygenase-1 and -2 in health and disease.

P E Lipsky1.   

Abstract

Animal and human data demonstrate that cyclooxygenase (COX)-2 upregulation in osteoarthritis and rheumatoid arthritis is associated with the pain and inflammation of the disease state. The COX-1 isoform, however, is a constitutive enzyme with homeostatic functions. Unlike conventional nonsteroidal anti-inflammatory drugs, which inhibit both forms of the COX enzyme, celecoxib inhibits COX-2 preferentially to COX-1 in vitro. Celecoxib reversed signs of arthritis and pain in an animal model as effectively as indomethacin. Data from murine studies as well as in vitro and epidemiologic data indicate that COX-2 plays a role in the development of colon cancer, and epidemiologic studies also suggest that COX inhibition can slow the progression of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10193997

Source DB:  PubMed          Journal:  Am J Orthop (Belle Mead NJ)        ISSN: 1078-4519


  10 in total

Review 1.  Role of cyclooxygenase-2 in gastric cancer development and progression.

Authors:  Jian Cheng; Xiao-Ming Fan
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

2.  Repetitive mechanical stretching modulates IL-1beta induced COX-2, MMP-1 expression, and PGE2 production in human patellar tendon fibroblasts.

Authors:  Guoguang Yang; Hee-Jeong Im; James H-C Wang
Journal:  Gene       Date:  2005-10-13       Impact factor: 3.688

3.  Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions.

Authors:  U Schönbeck; G K Sukhova; P Graber; S Coulter; P Libby
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

4.  Platelet antistaphylococcal responses occur through P2X1 and P2Y12 receptor-induced activation and kinocidin release.

Authors:  Darin A Trier; Kimberly D Gank; Deborah Kupferwasser; Nannette Y Yount; William J French; Alan D Michelson; Leon I Kupferwasser; Yan Q Xiong; Arnold S Bayer; Michael R Yeaman
Journal:  Infect Immun       Date:  2008-09-29       Impact factor: 3.441

5.  Progastrin and cyclooxygenase-2 in colorectal cancer.

Authors:  Peter C Konturek; Władysław Bielanski; Stanislaw J Konturek; Artur Hartwich; Piotr Pierzchalski; Macien Gonciarz; Krzysztof Marlicz; Teresa Starzynska; Monika Zuchowicz; Zbigniew Darasz; Jens P Götze; Jens F Rehfeld; Eckhart G Hahn
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

6.  A novel angiogenic role for prostaglandin F2alpha-FP receptor interaction in human endometrial adenocarcinomas.

Authors:  Kurt J Sales; Tammy List; Sheila C Boddy; Alistair R W Williams; Richard A Anderson; Zvi Naor; Henry N Jabbour
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

7.  The effects of a nonsteroidal anti-inflammatory drug on the degree of titanium implant osseointegration.

Authors:  Vesile Elif Toy; Serkan Dundar; Alihan Bozoglan
Journal:  J Oral Biol Craniofac Res       Date:  2020-07-03

8.  Effect of pre-operative medication with paracetamol and ketorolac on the success of inferior alveolar nerve block in patients with symptomatic irreversible pulpitis: a double-blind randomized clinical trial.

Authors:  Umesh Kumar; Akhil Rajput; Nidhi Rani; Pragnesh Parmar; Amandeep Kaur; Vivek Aggarwal
Journal:  J Dent Anesth Pain Med       Date:  2021-10-01

9.  Addition of 2 mg dexamethasone to improve the anesthetic efficacy of 2% lidocaine with 1:80,000 epinephrine administered for inferior alveolar nerve block to patients with symptomatic irreversible pulpitis in the mandibular molars: a randomized double-blind clinical trial.

Authors:  Vivek Aggarwal; Tanveer Ahmad; Mamta Singla; Alpa Gupta; Masoud Saatchi; Mukesh Hasija; Babita Meena; Umesh Kumar
Journal:  J Dent Anesth Pain Med       Date:  2022-07-26

Review 10.  The future of osteoarthritis therapeutics: targeted pharmacological therapy.

Authors:  A Mobasheri
Journal:  Curr Rheumatol Rep       Date:  2013-10       Impact factor: 4.592

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.